Cargando…
Clinical phase I/II trial to investigate neoadjuvant intensity-modulated short term radiation therapy (5 × 5 gy) and intraoperative radiation therapy (15 gy) in patients with primarily resectable pancreatic cancer - NEOPANC
BACKGROUND: The current standard treatment, at least in Europe, for patients with primarily resectable tumors, consists of surgery followed by adjuvant chemotherapy. But even in this prognostic favourable group, long term survival is disappointing because of high local and distant failure rates. Pos...
Autores principales: | Roeder, Falk, Timke, Carmen, Saleh-Ebrahimi, Ladan, Schneider, Lutz, Hackert, Thilo, Hartwig, Werner, Kopp-Schneider, Annette, Hensley, Frank W, Buechler, Markus W, Debus, Juergen, Huber, Peter E, Werner, Jens |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3323416/ https://www.ncbi.nlm.nih.gov/pubmed/22443802 http://dx.doi.org/10.1186/1471-2407-12-112 |
Ejemplares similares
-
Preoperative short-term radiation therapy (25 Gy, 2.5 Gy twice daily) for primary resectable rectal cancer (phase II)
por: Widder, J, et al.
Publicado: (2005) -
Intensity-modulated radiation therapy from 70Gy to 80Gy in prostate cancer: six- year outcomes and predictors of late toxicity
por: Jolnerovski, Maria, et al.
Publicado: (2017) -
Clinical Outcomes of Dose-Escalated Hypofractionated External Beam Radiation Therapy (5 Gy × 5 Fractions) for Spine Metastasis
por: Shin, Jacob Y., et al.
Publicado: (2022) -
Aggressive local treatment containing intraoperative radiation therapy (IORT) for patients with isolated local recurrences of pancreatic cancer: a retrospective analysis
por: Roeder, Falk, et al.
Publicado: (2012) -
Radiation optic neuropathy and retinopathy with low dose (20 Gy) radiation treatment
por: Peeler, Crandall E., et al.
Publicado: (2016)